SG10201810830UA - Cell culture compositions and methods for polypeptide production - Google Patents
Cell culture compositions and methods for polypeptide productionInfo
- Publication number
- SG10201810830UA SG10201810830UA SG10201810830UA SG10201810830UA SG10201810830UA SG 10201810830U A SG10201810830U A SG 10201810830UA SG 10201810830U A SG10201810830U A SG 10201810830UA SG 10201810830U A SG10201810830U A SG 10201810830UA SG 10201810830U A SG10201810830U A SG 10201810830UA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- cell culture
- polypeptide production
- culture compositions
- compositions
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 238000004113 cell culture Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000006143 cell culture medium Substances 0.000 abstract 2
- 230000010261 cell growth Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/005—Protein-free medium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261637778P | 2012-04-24 | 2012-04-24 | |
| US201261637780P | 2012-04-24 | 2012-04-24 | |
| US13/841,864 US20130281355A1 (en) | 2012-04-24 | 2013-03-15 | Cell culture compositions and methods for polypeptide production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201810830UA true SG10201810830UA (en) | 2018-12-28 |
Family
ID=49380652
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201810830UA SG10201810830UA (en) | 2012-04-24 | 2013-04-24 | Cell culture compositions and methods for polypeptide production |
| SG11201406903SA SG11201406903SA (en) | 2012-04-24 | 2013-04-24 | Cell culture compositions and methods for polypeptide production |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201406903SA SG11201406903SA (en) | 2012-04-24 | 2013-04-24 | Cell culture compositions and methods for polypeptide production |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20130281355A1 (ru) |
| EP (2) | EP2841561B1 (ru) |
| JP (4) | JP6367792B2 (ru) |
| KR (2) | KR102115052B1 (ru) |
| CN (2) | CN104428409A (ru) |
| AR (1) | AR090822A1 (ru) |
| AU (2) | AU2013251647B2 (ru) |
| BR (1) | BR112014026308A8 (ru) |
| CA (1) | CA2871006C (ru) |
| ES (1) | ES2716301T3 (ru) |
| HK (1) | HK1208496A1 (ru) |
| HR (1) | HRP20190484T1 (ru) |
| IL (1) | IL235235A0 (ru) |
| MX (2) | MX363493B (ru) |
| MY (1) | MY181513A (ru) |
| NZ (1) | NZ701791A (ru) |
| PL (1) | PL2841561T3 (ru) |
| RU (2) | RU2018146497A (ru) |
| SG (2) | SG10201810830UA (ru) |
| SI (1) | SI2841561T1 (ru) |
| WO (1) | WO2013163294A1 (ru) |
| ZA (2) | ZA201408092B (ru) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9181572B2 (en) | 2012-04-20 | 2015-11-10 | Abbvie, Inc. | Methods to modulate lysine variant distribution |
| US9334319B2 (en) | 2012-04-20 | 2016-05-10 | Abbvie Inc. | Low acidic species compositions |
| ES2798307T3 (es) | 2013-03-15 | 2020-12-10 | Hoffmann La Roche | Composiciones de cultivo de células con antioxidantes y procedimientos para la producción de polipéptidos |
| EP2968544A4 (en) * | 2013-03-15 | 2016-10-12 | Hoffmann La Roche | CELL CULTURE MEDIA AND METHOD FOR PRODUCING ANTIBODY |
| US9598667B2 (en) * | 2013-10-04 | 2017-03-21 | Abbvie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
| GB201708655D0 (en) | 2017-05-31 | 2017-07-12 | Ucb Biopharma Sprl | Cell culture methods |
| JP2020523030A (ja) * | 2017-06-16 | 2020-08-06 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | バイオリアクタにおいてのプロセスのアウトカムを予測するための、および、そのプロセスのモデリングのための方法 |
| EP3492582A1 (en) | 2017-12-01 | 2019-06-05 | UCB Biopharma SPRL | Cell culture methods |
| CN111500662A (zh) * | 2018-06-25 | 2020-08-07 | 深圳市菲鹏生物制药股份有限公司 | 调节cho-k1表达系统所分泌抗体的酸性峰含量的方法 |
| EP4051790A4 (en) * | 2019-10-31 | 2023-11-01 | William Marsh Rice University | GENETICALLY ENGINEERED CELLS FOR CONTROLLED PRODUCTION |
| PE20221770A1 (es) * | 2019-12-06 | 2022-11-11 | Regeneron Pharma | Composiciones de proteina anti-vegf y metodos para producir la misma |
| WO2021153723A1 (ja) | 2020-01-31 | 2021-08-05 | 中外製薬株式会社 | 着色を抑制したポリペプチドを含む組成物の製造方法 |
| JP7404929B2 (ja) | 2020-02-26 | 2023-12-26 | 富士フイルムビジネスイノベーション株式会社 | 発光装置、光学装置及び計測装置 |
| JP7404930B2 (ja) | 2020-02-26 | 2023-12-26 | 富士フイルムビジネスイノベーション株式会社 | 発光装置、光学装置及び計測装置 |
| GB202012991D0 (en) | 2020-08-20 | 2020-10-07 | Ucb Biopharma Sprl | Cell culture processes |
| CN116635416A (zh) * | 2020-12-22 | 2023-08-22 | 诺华股份有限公司 | 用于在细胞培养期间降低分泌的重组表达蛋白质中半胱氨酸残基的氧化水平的方法 |
| GB202105424D0 (en) | 2021-04-16 | 2021-06-02 | UCB Biopharma SRL | Cell culture processes |
| CN118076878A (zh) | 2021-09-02 | 2024-05-24 | 勃林格殷格翰国际公司 | 确定未来颜色值或相应属性及其装置的方法 |
| WO2023063611A1 (ko) * | 2021-10-12 | 2023-04-20 | 프레스티지바이오로직스 주식회사 | 항체 집단의 제조 방법 |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| JPS5863385A (ja) | 1981-10-02 | 1983-04-15 | ハナ・バイオロジツクス・インコ−ポレ−テツド | 免疫系由来の細胞用培地 |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| AU2353384A (en) | 1983-01-19 | 1984-07-26 | Genentech Inc. | Amplification in eukaryotic host cells |
| US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US4816401A (en) | 1985-09-09 | 1989-03-28 | University Of Rochester | Serum free cell culture medium |
| US5091178A (en) | 1986-02-21 | 1992-02-25 | Oncogen | Tumor therapy with biologically active anti-tumor antibodies |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| IL87737A (en) | 1987-09-11 | 1993-08-18 | Genentech Inc | Method for culturing polypeptide factor dependent vertebrate recombinant cells |
| AU632065B2 (en) | 1988-09-23 | 1992-12-17 | Novartis Vaccines And Diagnostics, Inc. | Cell culture medium for enhanced cell growth, culture longevity and product expression |
| US6048728A (en) | 1988-09-23 | 2000-04-11 | Chiron Corporation | Cell culture medium for enhanced cell growth, culture longevity, and product expression |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| JPH03180176A (ja) * | 1989-11-16 | 1991-08-06 | W R Grace & Co | 細胞培養のための基礎栄養培地 |
| EP0502036B1 (en) | 1989-11-22 | 1995-12-20 | Genentech, Inc. | Latency associated peptide and uses therefor |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| DK1136556T3 (da) | 1991-11-25 | 2005-10-03 | Enzon Inc | Fremgangsmåde til fremstilling af multivalente antigen-bindende proteiner |
| JPH07102147B2 (ja) * | 1992-03-16 | 1995-11-08 | 株式会社ミドリ十字 | ヒト血清アルブミンの着色抑制方法 |
| US5856179A (en) | 1994-03-10 | 1999-01-05 | Genentech, Inc. | Polypeptide production in animal cell culture |
| US5512477A (en) | 1994-04-21 | 1996-04-30 | Genzyme Corporation | Serum-free medium supplement |
| US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
| EP0802257B1 (fr) * | 1996-04-19 | 2002-08-21 | Societe Des Produits Nestle S.A. | Lignée immortalisée de cellules épithéliales du colon humain |
| ATE399855T1 (de) * | 1996-10-10 | 2008-07-15 | Invitrogen Corp | Tierzellkulturmedium mit pflanzlichen nährstoffen |
| US20020012991A1 (en) | 1997-04-07 | 2002-01-31 | Florence Chua Nee Ho Kit Fong | Cell culture media for enhanced protein production |
| US6171586B1 (en) | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
| US6160099A (en) * | 1998-11-24 | 2000-12-12 | Jonak; Zdenka Ludmila | Anti-human αv β3 and αv β5 antibodies |
| US20060286668A1 (en) | 1999-04-30 | 2006-12-21 | Invitrogen Corporation | Animal-cell culture media comprising non-animal or plant-derived nutrients |
| US6900056B2 (en) * | 2001-02-15 | 2005-05-31 | Centocor, Inc. | Chemically defined medium for cultured mammalian cells |
| EP1404813A4 (en) | 2001-06-13 | 2004-11-24 | Genentech Inc | METHOD FOR CULTIVATING ANIMAL CELLS AND POLYPEPTIDE PRODUCTION IN ANIMAL CELLS |
| GB0208041D0 (en) * | 2002-04-08 | 2002-05-22 | Lonza Biologics Plc | Method of culturing animal cells |
| AR047392A1 (es) | 2002-10-22 | 2006-01-18 | Wyeth Corp | Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines |
| GB0304799D0 (en) * | 2003-03-03 | 2003-04-09 | Glaxosmithkline Biolog Sa | Novel method |
| US20060104968A1 (en) | 2003-03-05 | 2006-05-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases |
| US7871607B2 (en) | 2003-03-05 | 2011-01-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
| EP1705251A4 (en) * | 2003-10-09 | 2009-10-28 | Kyowa Hakko Kirin Co Ltd | PROCESS FOR PRODUCING ANTIBODY COMPOSITION BY RNA INHIBITION OF FUNCTION OF $ G (A) 1,6-FUCOSYLTRANSFERASE |
| US7294484B2 (en) * | 2004-08-27 | 2007-11-13 | Wyeth Research Ireland Limited | Production of polypeptides |
| US20060051347A1 (en) | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
| JO3000B1 (ar) | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
| AU2005302516A1 (en) * | 2004-10-29 | 2006-05-11 | Centocor, Inc. | Chemically defined media compositions |
| CN100569940C (zh) * | 2006-08-16 | 2009-12-16 | 华东理工大学 | 人胚胎肾(hek)293细胞无血清培养基 |
| BRPI0716762A2 (pt) * | 2006-09-13 | 2013-09-24 | Abbott Lab | melhorias da cultura celular |
| BRPI0721097A2 (pt) | 2006-12-11 | 2014-07-01 | Hoffmann La Roche | Formulação parenteral de anticorpo abeta |
| US20100041146A1 (en) * | 2007-01-12 | 2010-02-18 | Nippon Sheet Glass Company, Limited | Three-dimensional cell culture carrier and method for cell culture using the same |
| EP2183358B1 (en) * | 2007-07-20 | 2013-03-27 | Dongguk University Industry Academic Cooperation Foundation | Method for the preparation of dermal papilla tissue employing mesenchymal stem cells |
| CA2698103A1 (en) * | 2007-08-31 | 2009-03-05 | Amgen Inc. | Solid-state protein formulation |
| KR101286895B1 (ko) * | 2008-04-17 | 2013-07-16 | 와이어쓰 엘엘씨 | 골 형태발생 단백질의 개선된 생산 방법 |
| JP2012503487A (ja) * | 2008-09-26 | 2012-02-09 | シェーリング コーポレイション | 高力価抗体の製造 |
| JO3672B1 (ar) * | 2008-12-15 | 2020-08-27 | Regeneron Pharma | أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9). |
| US9540426B2 (en) * | 2009-10-06 | 2017-01-10 | Bristol-Myers Squibb Company | Mammalian cell culture processes for protein production |
| PL2563904T3 (pl) | 2010-04-26 | 2015-06-30 | Novartis Ag | Udoskonalona pożywka do hodowli komórkowej |
-
2013
- 2013-03-15 US US13/841,864 patent/US20130281355A1/en not_active Abandoned
- 2013-04-24 BR BR112014026308A patent/BR112014026308A8/pt not_active Application Discontinuation
- 2013-04-24 KR KR1020147032389A patent/KR102115052B1/ko active IP Right Grant
- 2013-04-24 CN CN201380032959.7A patent/CN104428409A/zh active Pending
- 2013-04-24 SG SG10201810830UA patent/SG10201810830UA/en unknown
- 2013-04-24 JP JP2015509107A patent/JP6367792B2/ja active Active
- 2013-04-24 AU AU2013251647A patent/AU2013251647B2/en active Active
- 2013-04-24 CN CN202010250367.4A patent/CN111440758A/zh active Pending
- 2013-04-24 NZ NZ701791A patent/NZ701791A/en unknown
- 2013-04-24 AR ARP130101367 patent/AR090822A1/es unknown
- 2013-04-24 RU RU2018146497A patent/RU2018146497A/ru unknown
- 2013-04-24 RU RU2014147018A patent/RU2678142C2/ru active
- 2013-04-24 CA CA2871006A patent/CA2871006C/en active Active
- 2013-04-24 SG SG11201406903SA patent/SG11201406903SA/en unknown
- 2013-04-24 EP EP13720203.2A patent/EP2841561B1/en not_active Revoked
- 2013-04-24 PL PL13720203T patent/PL2841561T3/pl unknown
- 2013-04-24 KR KR1020207014171A patent/KR102339106B1/ko active IP Right Grant
- 2013-04-24 ES ES13720203T patent/ES2716301T3/es active Active
- 2013-04-24 EP EP18213796.8A patent/EP3533864A1/en active Pending
- 2013-04-24 SI SI201331376T patent/SI2841561T1/sl unknown
- 2013-04-24 MX MX2014012838A patent/MX363493B/es unknown
- 2013-04-24 WO PCT/US2013/037992 patent/WO2013163294A1/en active Application Filing
- 2013-04-24 MY MYPI2014003007A patent/MY181513A/en unknown
-
2014
- 2014-10-21 IL IL235235A patent/IL235235A0/en unknown
- 2014-10-23 MX MX2019003427A patent/MX2019003427A/es unknown
- 2014-11-05 ZA ZA2014/08092A patent/ZA201408092B/en unknown
-
2015
- 2015-09-17 HK HK15109118.1A patent/HK1208496A1/xx unknown
-
2017
- 2017-11-03 ZA ZA2017/07452A patent/ZA201707452B/en unknown
-
2018
- 2018-07-05 JP JP2018128429A patent/JP7323272B2/ja active Active
-
2019
- 2019-03-11 HR HRP20190484TT patent/HRP20190484T1/hr unknown
- 2019-04-02 AU AU2019202259A patent/AU2019202259B2/en active Active
-
2021
- 2021-03-16 JP JP2021042702A patent/JP2021104023A/ja not_active Withdrawn
-
2023
- 2023-07-28 JP JP2023123219A patent/JP2023156371A/ja active Pending
- 2023-10-30 US US18/497,162 patent/US20240093143A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201810830UA (en) | Cell culture compositions and methods for polypeptide production | |
| SG10201809452RA (en) | Cell culture compositions with antioxidants and methods for polypeptide production | |
| MY156588A (en) | Systems using cell culture for production of isoprene | |
| MX2015011781A (es) | Medio de cultivo celular y metodos de produccion de anticuerpos. | |
| WO2010096588A3 (en) | Cell culture media containing combinations of proteins | |
| MY186219A (en) | Production of proteins in glutamine-free cell culture media | |
| WO2014143744A3 (en) | Benzylisoquinoline alkaloids (bia) producing microbes, and methods of making and using the same | |
| EP3546570A4 (en) | KIT WITH MEDIUM FOR THE CULTURE OF SERUM-FREE IMMUNELL CELLS, METHOD FOR THE CULTURE OF IMMUNAL CELLS BY USE OF THE KIT, SERUM-FREE IMMUNE CELL CULTURE RECEIVED BY THE KIT OR CULTURE METHOD AND COSMETIC COMPOSITION | |
| WO2012019122A3 (en) | Simplified basic media for human pluripotent cell culture | |
| SG10201805291TA (en) | Production of heterodimeric proteins | |
| MY170720A (en) | Antibody formulations | |
| GB201203085D0 (en) | Hydrogels | |
| MY178338A (en) | Compositions and methods for biological production of lactate from c1 compounds using lactate dehydrogenase transformants | |
| WO2012003402A3 (en) | Compositions and methods for culturing microorganisms | |
| EA201590550A1 (ru) | Композиции и способы получения гликопротеинов | |
| EA201492185A1 (ru) | Способ получения рекомбинантной идуронат-2-сульфатазы | |
| WO2011129462A3 (en) | A YEAST EXTRACT CONTAINING γ-Glu-X OR γ-Glu-X-Gly AND A METHOD FOR PRODUCING THE SAME | |
| MX2021001981A (es) | Metodos para preparar un poloxamero para usar en medio de cultivo celular. | |
| EP4039796A4 (en) | METHOD FOR PRODUCING COMPOSITION FOR CELL CULTURE, COMPOSITION FOR CELL CULTURE OBTAINED THEREBY, AND CELL CULTURE METHOD USING SAME | |
| WO2014049382A3 (en) | Ethylenediamine fermentative production by a recombinant microorganism | |
| EP3511410A4 (en) | MEDIUM FOR THE CULTURE OF STEM CELLS, METHOD FOR THE CULTURE OF STEM CELLS, STEM CELL GROWTH PROMOTER AND COMPOSITION AND METHOD FOR THE PRODUCTION THEREOF | |
| MY169178A (en) | Direct and indirect organogenesis of jatropha | |
| EA200900984A1 (ru) | Улучшение клеточного роста | |
| WO2012054935A3 (en) | Formation of hematopoietic progenitor cells from mesenchymal stem cells | |
| WO2012107445A3 (en) | Soft substrate for cell culture and process for preparing the same |